Freedom Meditech Obtains $7,000,000 Series B Financing Round

  • Feed Type
  • Date
    8/6/2013
  • Company Name
    Freedom Meditech
  • Mailing Address
    10455 Pacific Center Court San Diego, CA 92121
  • Company Description
    Freedom Meditech is focused on the development and commercialization of medical device technologies that provide users worldwide with a more “free and healthy” alternative to existing diagnostic tools on the market.
  • Website
    http://www.freedom-meditech.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Funds will support the U.S. commercial launch of the ClearPath DS-120 Lens Fluorescence Biomicroscope which was cleared by the U.S. Food and Drug Administration (FDA) earlier this year. The capital raised will also support the clinical development of the I-SugarX, a non-invasive personal glucose meter for people with diabetes that is operated by holding a small handheld device in front of the eye.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.